The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
Abstract
Objectives: This is the second of a pair of studies designed to evaluate the efficacy and safety of onabotulinumtoxinA (BOTOX®) for prophylaxis of headaches in adults with chronic migraine. Methods: PREEMPT 2 was a phase 3 study, with a 24-week, double-blind, placebo-controlled phase, followed by a 32-week, open-label phase. Subjects were randomized (1:1) to injections of onabotulinumtoxinA (155U–195U; n = 347) or placebo ( n = 358) every 12 weeks for two cycles. The primary efficacy endpoint was mean change in headache days per 28 days from baseline to weeks 21–24 post-treatment. Results: OnabotulinumtoxinA was statistically significantly superior to placebo for the primary endpoint, frequency of headache days per 28 days relative to baseline (−9.0 onabotulinumtoxinA/−6.7 placebo, p < .001). OnabotulinumtoxinA was significantly favoured in all secondary endpoint comparisons. OnabotulinumtoxinA was safe and well tolerated, with few treatment-related adverse events. Few patients (3.5% onabotulinumtoxinA/1.4% placebo) discontinued due to adverse events. Conclusions: The results of PREEMPT 2 demonstrate that onabotulinumtoxinA is effective for prophylaxis of headache in adults with chronic migraine. Repeated onabotulinumtoxinA treatments were safe and well tolerated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A six-item short-form survey for measuring headache impact: The HIT-6™
Kosinski, M., Bayliss, M. S., Bjorner, J. B., Ware, J. E., Garber, W. H., Batenhorst, A., Cady, R., Dahlöf, C. G. H., Dowson, A., & Tepper, S. (2003) · Quality of Life Research · doi:10.1023/a:1026119331193 · Cited by 1,376 · cited 5×
“OnabotulinumtoxinA-treated patients in PREEMPT 2 had improved functioning compared with placebo-treated patients, as demonstrated by a significant decline in disability (mean change from baseline in total HIT-6 score) at all time points (p .001).”
BackgroundInfluentialAurora, S., Dodick, D., Turkel, C., DeGryse, R., Silberstein, S., Lipton, R., Diener, H., & Brin, M. (2010) · Cephalalgia · doi:10.1177/0333102410364676 · Cited by 1,047
Self-citationNew Appendix Criteria Open for a Broader Concept of Chronic Migraine
Olesen, J., Bousser, M.-G., Diener, H.-C., Dodick, D., First, M., Goadsby, P., Göbel, H., Lainez, M., Lance, J., Lipton, R., et al. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01172.x · Cited by 909
Self-citationEpidemiology of Chronic Daily Headache in the General Population
Castillo, J., Muñoz, P., Guitera, V., & Pascual, J. (1999) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1999.3903190.x · Cited by 714
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
Buse, D. C., Manack, A., Serrano, D., Turkel, C., & Lipton, R. B. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.192492 · Cited by 622
Self-citationPrevalence of Frequent Headache in a Population Sample
Scher, A. I., Stewart, W. F., Liberman, J., & Lipton, R. B. (1998) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1998.3807497.x · Cited by 606
Self-citationDiener, H.-C., Bussone, G., Oene, J. V., Lahaye, M., Schwalen, S., & Goadsby, P. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01326.x · Cited by 561
Self-citationSilberstein, S. D., Lipton, R. B., Dodick, D. W., Freitag, F. G., Ramadan, N., Mathew, N., Brandes, J. L., Bigal, M., Saper, J., Ascher, S., et al. (2007) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00684.x · Cited by 497
Self-citationChronic migraine in the population: Burden, diagnosis, and satisfaction with treatment
Bigal, M. E., Serrano, D., Reed, M., & Lipton, R. B. (2008) · Neurology · doi:10.1212/01.wnl.0000323925.29520.e7 · Cited by 490
Self-citationBotulinum toxin type a induces direct analgesic effects in chronic neuropathic pain
Ranoux, D., Attal, N., Morain, F., & Bouhassira, D. (2008) · Annals of Neurology · doi:10.1002/ana.21427 · Cited by 459
Medication-overuse headache: a worldwide problem
Diener, H.-C., & Limmroth, V. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00824-5 · Cited by 455
Self-citationLocalized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
Brin, M. F., Fahn, S., Moskowitz, C., Friedman, A., Shale, H. M., Greene, P. E., Blitzer, A., List, T., Lange, D., Lovelace, R. E., et al. (1987) · Movement Disorders · doi:10.1002/mds.870020402 · Cited by 417
Self-citationBotulinum toxin in the treatment of myofascial pain syndrome
Cheshire, W. P., Abashian, S. W., & Mann, D. J. (1994) · Pain · doi:10.1016/0304-3959(94)90048-5 · Cited by 340
Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults
Silberstein, S., Tfelt-Hansen, P., Dodick, D., Limmroth, V, Lipton, R., Pascual, J., Wang, S., & for the Task Force of the International Headache Society Clinical Trials Subcommittee (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01555.x · Cited by 303
Self-citationBotulinum toxin A and chronic low back pain: A randomized, double-blind study
Foster, L., Clapp, L., Erickson, M., & Jabbari, B. (2001) · Neurology · doi:10.1212/wnl.56.10.1290 · Cited by 297
Mathew, N. T., Frishberg, B. M., Gawel, M., Dimitrova, R., Gibson, J., Turkel, C., & BOTOX CDH Study Group (2005) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.05066.x · Cited by 266
Self-citationDevelopment and Validation of the Migraine‐Specific Quality of Life Questionnaire
Jhingran, P., Osterhaus, J. T., Miller, D. W., Lee, J. T., & Kirchdoerfer, L. (1998) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1998.3804295.x · Cited by 252
Double‐Blind Trial of Fluoxetine: Chronic Daily Headache and Migraine
Saper, J. R., Silberstein, S. D., Lake, A. E., & Winters, M. E. (1994) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1994.hed3409497.x · Cited by 234
Self-citationDodick, D. W., Mauskop, A., Elkind, A. H., DeGryse, R., Brin, M. F., Silberstein, S. D., & BOTOX CDH Study Group (2005) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.05068.x · Cited by 221
Self-citationPrevalence and description of chronic daily headache in the general population in France
Lantéri-Minet, M., Auray, J.-P., El Hasnaoui, A., Dartigues, J.-F., Duru, G., Henry, P., Lucas, C., Pradalier, A., Chazot, G., & Gaudin, A.-F. (2003) · Pain · doi:10.1016/s0304-3959(02)00348-2 · Cited by 213
Dodick, D. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp042897 · Cited by 191
Self-citationManagement of Spasticity Associated Pain with Botulinum Toxin A
Wissel, J., Müller, J., Dressnandt, J., Heinen, F., Naumann, M., Topka, H., & Poewe, W. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00146-9 · Cited by 185
Silberstein, S. D., Stark, S. R., Lucas, S. M., Christie, S. N., Degryse, R. E., & Turkel, C. C. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.9.1126 · Cited by 176
Self-citationSilberstein, S., Göbel, H., Jensen, R., Elkind, A., DeGryse, R., Walcott, J., & Turkel, C. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01114.x · Cited by 174
Self-citationSafety and efficacy of botulinum toxin type A following long‐term use
Naumann, M., Albanese, A., Heinen, F., Molenaers, G., & Relja, M. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01652.x · Cited by 169
Topiramate in the Treatment of Chronic Migraine
Silvestrini, M., Bartolini, M., Coccia, M., Baruffaldi, R., Taffi, R., & Provinciali, L. (2003) · Cephalalgia · doi:10.1046/j.1468-2982.2003.00592.x · Cited by 162
Coeytaux, R. R., Kaufman, J. S., Chao, R. A., Mann, J. D., & DeVellis, R. F. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.05.010 · Cited by 161
Aurora, S. K., Gawel, M. J., Brandes, J. L., Pokta, S., VanDenburgh, A. M., & for the BOTOX North American Episodic Migraine Study Group (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00624.x · Cited by 156
Self-citationSaper, J. R., Lake, A. E., Cantrell, D. T. C., Winner, P. K., & White, J. (2002) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2002.02122.x · Cited by 142
Primary chronic daily headache and its subtypes in adolescents and adults
BIGAL, M. E., Lipton, R. B., Tepper, S. J., Rapoport, A. M., & Sheftell, F. (2004) · Neurology · doi:10.1212/01.wnl.0000137039.08724.18 · Cited by 140
Self-citationRelja, M., Poole, A., Schoenen, J., Pascual, J., Lei, X., & Thompson, C. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01315.x · Cited by 132
The Importance of Placebo in Headache Research
Diener, H., Schorn, C. F., Bingel, U., & Dodick, D. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01660.x · Cited by 117
Self-citationCole, J. C., Lin, P. L., & Rupnow, M. F. T. (2007) · Quality of Life Research · doi:10.1007/s11136-007-9217-1 · Cited by 101
Field Testing Alternative Criteria for Chronic Migraine
Bigal, M., Tepper, S. J., Sheftell, F., Rapoport, A. M., & Lipton, R. B. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01128.x · Cited by 58
Self-citationLipton, R. B., & BIGAL, M. E. (2003) · Neurology · doi:10.1212/wnl.61.2.154 · Cited by 54
Self-citationBotulinum toxin type A for the treatment of migraine
Aurora, S. K. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1085 · Cited by 35
Self-citation
Cited by
Aurora, S., Dodick, D., Turkel, C., DeGryse, R., Silberstein, S., Lipton, R., Diener, H., & Brin, M. (2010) · Cephalalgia · doi:10.1177/0333102410364676 · Cited by 1,047
Self-citationDodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., Diener, H., & Brin, M. F. (2010) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01678.x · Cited by 994
Self-citationFremanezumab for the Preventive Treatment of Chronic Migraine
Silberstein, S. D., Dodick, D. W., Bigal, M. E., Yeung, P. P., Goadsby, P. J., Blankenbiller, T., Grozinski-Wolff, M., Yang, R., Ma, Y., & Aycardi, E. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709038 · Cited by 792
Self-citationAilani, J., Burch, R. C., Robbins, M. S., & the Board of Directors of the American Headache Society (2021) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.14153 · Cited by 766
Tepper, S., Ashina, M., Reuter, U., Brandes, J. L., Doležil, D., Silberstein, S., Winner, P., Leonardi, D., Mikol, D., & Lenz, R. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30083-2 · Cited by 722
Self-citation
Metadata
- Authors
- Diener, H., Dodick, D., Aurora, S., Turkel, C., DeGryse, R., Lipton, R., Silberstein, S., & Brin, M.
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 2010-03-17
- Volume
- 30
- Issue
- 7
- Pages
- 804-814
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W4230120862
- Cited by
- 960
- References
- 36
- FWCI
- 32.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.